Jigar has spent nearly 20 years in the biotechnology industry in a variety of business functions. He rejoined Constellation in May 2017 as the company’s chief executive officer from Jounce Therapeutics, where he held the role of chief business officer. At Jounce, Jigar was the first employee and helped build the company from its inception to a 100-person, publicly traded research and development organization. Previously, he served as head of corporate development at Constellation, where he led business development, strategy and program and alliance management functions. Prior to Constellation, Jigar worked with Red Abbey Venture Partners, elevating from a Kauffman fellow, to principal and finally a venture partner. Earlier in his career, Jigar held roles of increasing responsibility at Biogen and A.T. Kearney. He earned a MBA Columbia University and a B.A. in biochemistry and economics from Rutgers University.